Please log in to determine if you are eligible to purchase PT Programs.
CAP/ACMG APOLIPOPROTEIN E GENOTYPING - APOE
APOE
Analytes/procedures in bold type are regulated for proficiency testing by the Centers for Medicare & Medicaid Services (CMS).

Analyte/Procedure Challenges per Shipment Number of Shipments
Apolipoprotein E (APOE) genotyping 3 Two shipments per year

This Survey is designed for laboratories utilizing APOE testing for hyperlipoproteinemia type III and Alzheimer diseases and will test for APOE e2, APOE e3, and APOE e4.


Program Information

  • Three 10.0‑μg extracted DNA specimens

Shipping Schedule

  • Shipment A: March 4
  • Shipment B: September 16